Physicochemical control of multilineage emergence
多谱系出现的物理化学控制
基本信息
- 批准号:10714338
- 负责人:
- 金额:$ 37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:CellsChemicalsClinicalCommunicationCuesDevelopmental BiologyDiseaseEmbryoExtracellular MatrixGerm LayersGoalsHumanHuman DevelopmentInvestigationMechanicsMetabolic DiseasesMicrofluidicsModelingMorphogenesisOrganOrganoidsPatientsPatternPopulationProcessRegenerative MedicineRoleSpecific qualifier valueTechnologyTissue EngineeringTissuesVariantbioscaffolddevelopmental diseasegastrulationholistic approachimprovedinduced pluripotent stem cellmatrigelmechanical signalparacrineregenerative approachself assemblyself organizationself-renewalstem cell fatestem cell modelstem cell nichetool
项目摘要
Project Summary
Human induced pluripotent stem cells (iPSCs) are unique in that they retain their ability to indefinitely self-renew
while maintaining the capacity to self-organize and differentiate into both embryonic and extraembryonic
lineages. iPSCs have emerged as a powerful tool to study human development, and disease, and have been
integrated with tissue engineering approaches for regenerative medicine applications. To fulfill the promise of
iPSC clinical utility, further investigation of the role of the stem cell niche in iPSC morphogenesis, lineage
specification, and functional maturation is needed. While organoid approaches have revolutionized our ability to
mimic organ-level function in a dish, they typically are comprised of cells from a single germ layer, missing critical
cues shared by surrounding populations including the microvasculature and stroma. In addition, organoids are
generated in ill-defined matrices such as Matrigel, which suffers from batch-to-batch variation, and limited
tunability. To this end, we propose using micropatterned induced gastrulation models to better understand how
paracrine and mechanical cues guide primitive stem cell fate. In addition, by leveraging assembloid technologies,
synthetic extracellular matrix mimics, and dynamic microfluidic culture, we aim to better understand multi-germ
layer interactions during tissue specification. Finally, we propose that improved iPSC derivatives can be used
to better understand patient-specific differences in metabolic disorders. Collectively, we propose that using an
integrative approach will permit iPSCs to be a powerful testbed for studying developmental biology and disease
processes.
项目摘要
人类诱导多能干细胞(iPSC)的独特之处在于它们保留了无限期自我更新的能力,
同时保持自我组织和分化成胚胎和胚外的能力
血统iPSC已经成为研究人类发育和疾病的有力工具,
与再生医学应用的组织工程方法相结合。履行…的诺言
iPSC临床效用,进一步研究干细胞生态位在iPSC形态发生、谱系
规范和功能成熟是必要的。虽然类器官方法已经彻底改变了我们的能力,
在培养皿中模拟器官水平的功能,它们通常由来自单个胚层的细胞组成,
包括微血管和基质在内的周围人群共享的线索。此外,类器官是
在定义不清的基质(如Matrigel)中生成,其存在批次间差异,
可调性为此,我们建议使用微模式诱导原肠胚形成模型来更好地了解如何
旁分泌和机械信号引导原始干细胞的命运。此外,通过利用仿人技术,
合成细胞外基质模拟物和动态微流控培养,我们的目标是更好地了解多细菌
组织规范期间的层相互作用。最后,我们建议可以使用改进的iPSC衍生物
以更好地了解代谢紊乱的患者特异性差异。总的来说,我们建议使用
综合方法将使iPSC成为研究发育生物学和疾病的强大试验平台
流程.
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Vascularized liver-on-a-chip model to investigate nicotine-induced dysfunction.
- DOI:10.1063/5.0172677
- 发表时间:2023-12
- 期刊:
- 影响因子:3.2
- 作者:Wang, Eric;Andrade, Melisa J.;Smith, Quinton
- 通讯作者:Smith, Quinton
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Quinton Smith其他文献
Quinton Smith的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Quinton Smith', 18)}}的其他基金
Elucidating the Effects of Shear and Confinement on Endothelial Cell Differentiation
阐明剪切和限制对内皮细胞分化的影响
- 批准号:
9195211 - 财政年份:2016
- 资助金额:
$ 37万 - 项目类别:
相似海外基金
Plastic Chemicals in Pediatric Cardiopulmonary Bypass: Evaluating Cardiac Toxicity and Investigating Clinical Alternatives
儿科心肺绕道中的塑料化学品:评估心脏毒性并研究临床替代方案
- 批准号:
10677964 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT
用于临床前发现、评估和开发的化学品和药物的注册、储存和分配
- 批准号:
10797066 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT
用于临床前发现评估和开发的化学品和药物的注册、储存和分配
- 批准号:
10458181 - 财政年份:2021
- 资助金额:
$ 37万 - 项目类别:
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT
用于临床前发现评估和开发的化学品和药物的注册、储存和分配
- 批准号:
10577410 - 财政年份:2021
- 资助金额:
$ 37万 - 项目类别:
Development and clinical application of low molecular chemicals that modulate myosin light chain kinase for the treatment of heart failure with preserved ejection fraction
调节肌球蛋白轻链激酶的低分子化学药物治疗射血分数保留性心力衰竭的开发及临床应用
- 批准号:
18H04050 - 财政年份:2018
- 资助金额:
$ 37万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
用于临床前和临床研究的散装化学品和散装药物成分的制造
- 批准号:
9915787 - 财政年份:2017
- 资助金额:
$ 37万 - 项目类别:
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
用于临床前和临床研究的散装化学品和散装药物成分的制造
- 批准号:
10551125 - 财政年份:2017
- 资助金额:
$ 37万 - 项目类别:
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
用于临床前和临床研究的散装化学品和散装药物成分的制造
- 批准号:
10329855 - 财政年份:2017
- 资助金额:
$ 37万 - 项目类别:
Title: Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery, Evaluation and Development
标题:用于临床前发现、评估和开发的化学品和药物的注册、储存和分销
- 批准号:
9433586 - 财政年份:2017
- 资助金额:
$ 37万 - 项目类别:
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
用于临床前和临床研究的散装化学品和散装药物成分的制造
- 批准号:
10075834 - 财政年份:2017
- 资助金额:
$ 37万 - 项目类别:














{{item.name}}会员




